|
MED-EL is a global technology company that researches in the field of hearing loss and develops and manufactures implantable hearing systems. These include cochlear implants, middle ear implants, bone conduction hearing implants, electric acoustic stimulation hearing implant systems and auditory brainstem implants. The company is headquartered in Innsbruck, Austria and was founded in 1990. MED-EL is a private company and is managed by its co-owner Ingeborg Hochmair, who is an internationally acclaimed scientist and researcher.〔(【引用サイトリンク】url=http://www.laskerfoundation.org/awards/pdf/2013_c_hochmair.pdf )〕 ==Background== Austrian scientists Ingeborg and Erwin Hochmair developed the world’s first micro-electronic multichannel cochlear implant. The implantation of this device took place in 1977 in Vienna and was a milestone in the treatment of deafness .〔(【引用サイトリンク】url=http://cochlearimplantonline.com/site/journey-to-developing-med-els-cochlear-implant-interview-with-dr-ingeborg-and-professor-erwin-hochmair-founders-of-med-el/ )〕 After further developing the technology the Hochmair’s went on to found MED-EL, in Innsbruck, Austria in 1990. Since 2003, the American physiologist and award-winning inventor Geoffrey R. Ball has become CTO of the company’s business unit VIBRANT MED-EL.〔(【引用サイトリンク】url=http://www.lifeaward.org/wp/prof-geoffrey-ball/ )〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「MED-EL」の詳細全文を読む スポンサード リンク
|